Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT07274228

Tamsulosin and the Risk of Serious Adverse Events

Conditions: Chronic Kidney Disease (CKD)

Sex: Male

Ages: 66 Years – N/A

Healthy volunteers: No

Enrollment: 14000

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Location: London Health Sciences Centre Research Institute London Ontario

Summary

This is a population-based cohort study assessing whether initiating a higher dose of tamsulosin (0.8 mg/day) compared to a lower dose (0.4 mg/day) in older adults with advanced chronic kidney disease (CKD) (an estimated glomerular filtration rate (eGFR) \

Eligibility Criteria

Inclusion Criteria: The cohort will include older adult men aged 66 years or older with advanced CKD (an eGFR \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07274228). StuddyBuddy aggregates publicly available trial information.